These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33996162)

  • 1. Posterior Reversible Leukoencephalopathy Syndrome in a Patient after Acute COVID-19 Infection.
    Kobaidze K; Shin YM; Japaridze M; Karakis I; Wu X
    Case Rep Neurol Med; 2021; 2021():5564802. PubMed ID: 33996162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome during convalescence from COVID-19.
    Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI
    Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958
    [No Abstract]   [Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report.
    Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M
    BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review.
    Wang L; Wang Z; Huang R; Li W; Zheng D
    Medicine (Baltimore); 2024 Feb; 103(5):e37192. PubMed ID: 38306528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient.
    Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M
    J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19.
    Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F
    Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases.
    Wijeratne T; Wijeratne C; Karimi L; Sales C; Crewther SG
    Front Neurol; 2020; 11():600544. PubMed ID: 33584499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome secondary to blood transfusion.
    Singh K; Gupta R; Kamal H; Silvestri NJ; Wolfe GI
    J Clin Neurosci; 2015 Mar; 22(3):592-4. PubMed ID: 25542590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior reversible encephalopathy syndrome in patients with COVID-19.
    Parauda SC; Gao V; Gewirtz AN; Parikh NS; Merkler AE; Lantos J; White H; Leifer D; Navi BB; Segal AZ
    J Neurol Sci; 2020 Sep; 416():117019. PubMed ID: 32679347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior reversible encephalopathy syndrome after renal transplant: a simple solution for a complicated patient.
    Haughey D; Narsipur SS
    Case Rep Nephrol Dial; 2015; 5(1):20-5. PubMed ID: 25849670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia.
    Elhassan M; Saidahmed O; Adebayo A; Archibald N
    Cureus; 2021 Jan; 13(1):e12794. PubMed ID: 33500867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature.
    Motolese F; Ferrante M; Rossi M; Magliozzi A; Sbarra M; Ursini F; Marano M; Capone F; Travaglino F; Antonelli Incalzi R; Di Lazzaro V; Pilato F
    J Neurol; 2021 Dec; 268(12):4407-4414. PubMed ID: 34291313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature.
    González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS
    Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain MRI findings in COVID-19 patients with PRES: A systematic review.
    Yeahia R; Schefflein J; Chiarolanzio P; Rozenstein A; Gomes W; Ali S; Mehta H; Al-Mufti F; McClelland A; Gulko E
    Clin Imaging; 2022 Jan; 81():107-113. PubMed ID: 34700172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior Reversible Encephalopathy Syndrome.
    Gewirtz AN; Gao V; Parauda SC; Robbins MS
    Curr Pain Headache Rep; 2021 Feb; 25(3):19. PubMed ID: 33630183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
    Tetsuka S; Nonaka H
    BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: Case series and literature review.
    Hixon AM; Thaker AA; Pelak VS
    Eur J Neurol; 2021 Oct; 28(10):3289-3302. PubMed ID: 34115917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Acute Toxic Leukoencephalopathy and Posterior Reversible Encephalopathy Syndrome.
    Özütemiz C; Roshan SK; Kroll NJ; Rykken JB; Ott F; McKinney AM
    J Neuroimaging; 2018 Sep; 28(5):535-541. PubMed ID: 29797465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
    Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
    Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19.
    Cisowska-Adamiak M; Sakwińska K; Szymkuć-Bukowska I; Goclik A; Lunitz I; Mackiewicz-Milewska M
    Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.